Serotype replacement in disease after pneumococcal vaccination

DM Weinberger, R Malley, M Lipsitch - The Lancet, 2011 - thelancet.com
Vaccination with heptavalent pneumococcal conjugate vaccine (PCV7) has significantly
reduced the burden of pneumococcal disease and has had an important public health …

Impact of conjugate pneumococcal vaccines on antibiotic resistance

R Dagan, KP Klugman - The Lancet infectious diseases, 2008 - thelancet.com
Reduction of drug-resistant Streptococcus pneumoniae (DRSP) by pneumococcal conjugate
vaccines (PCVs) has recently become a reality. We now know that (1) most clinically …

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

WP Hausdorff, B Hoet, L Schuerman - BMC pediatrics, 2010 - Springer
Background Introduction of the 7-valent pneumococcal conjugate vaccine (7vCRM) in
several countries has led to a rapid, significant drop in vaccine-type invasive pneumococcal …

Global prevailing and emerging pediatric pneumococcal serotypes

EDG McIntosh, RR Reinert - Expert review of vaccines, 2011 - Taylor & Francis
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths among
children younger than 5 years of age worldwide. The 7-valent pneumococcal conjugate …

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

A Torres, P Bonanni, W Hryniewicz… - European Journal of …, 2015 - Springer
Individuals< 2 years and≥ 50 years of age, as well as those with other specific risk factors,
are especially vulnerable to invasive pneumococcal disease (IPD). Conjugate vaccines …

Pneumococcal nasopharyngeal carriage in children< 5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern …

S Ben-Shimol, N Givon-Lavi, D Greenberg… - Human vaccines & …, 2016 - Taylor & Francis
ABSTRACT The 7-valent and the 13-valent pneumococcal conjugate vaccines (PCV7 and
PCV13, respectively) were introduced to the Israeli National Immunization plan in July 2009 …

Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France

R Cohen, C Levy, E Bonnet, S Grondin, V Desvignes… - Vaccine, 2010 - Elsevier
To determine whether the use of seven valent pneumococcal conjugate vaccine (PCV7)
caused a shift in the Streptococcus pneumoniae serotypes distribution and whether it …

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination

T Van Effelterre, MR Moore, F Fierens, CG Whitney… - Vaccine, 2010 - Elsevier
Universal infant vaccination with the 7-valent pneumococcal conjugate vaccine (PCV7) has
nearly eliminated PCV7-serotype invasive pneumococcal disease (IPD) in young US …

Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil

AL Andrade, YM Ternes, MA Vieira, WG Moreira… - PLoS …, 2014 - journals.plos.org
Background 10-valent conjugate pneumococcal vaccine/PCV10 was introduced in the
Brazilian National Immunization Program along the year of 2010. We assessed the direct …

Predisposing factors for acute otitis media in infancy

F Ladomenou, A Kafatos, Y Tselentis, E Galanakis - Journal of infection, 2010 - Elsevier
BACKGROUND: Factors predisposing to acute otitis media (AOM) are not thoroughly
understood. OBJECTIVES: In this study we prospectively investigated incidence rates and …